title: [Bone and bone related biochemical examinations. Hormone and hormone related substances. The measurement of circulating fibroblast growth factor 23 (FGF-23)].
abstract: Fibroblast growth factor 23 (FGF-23) is a phosphaturic peptide involving in the development of hypophosphatemic rickets/osteomalacia. FGF-23 assays are known to be useful for the diagnosis of hypophosphatemia. Now three different two-site enzyme-linked immunosorbent assays a C-terminal human FGF23 enzyme-linked immunosorbent assay (ELISA) (Immunotopics, California), an intact human FGF23 ELISA (Immunotopics, California), and another intact human FGF23 ELISA (Kainos Laboratories, Japan) are available for the diagnosis.
authors.affiliation: Osaka City University Graduate School of Medicine, Department of Metabolism, Endocrinology and Molecular Medicine.
authors.forename: Keisuke
authors.initials: K
authors.lastname: Kobayashi
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Imanishi
mesh_terms: D004797:Enzyme-Linked Immunosorbent Assay; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000097:blood*; D006801:Humans; D017674:Hypophosphatemia / Q000175:diagnosis
chemical_list: C000717427:FGF23 protein, human; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23